A randomized controlled clinical trial of palliative therapies for patients with inoperable esophageal cancer

American Journal of Gastroenterology

Volumn 104, Issue 7, 2009, Pages 1674-1685

  Shenfine, Jonathan ^a   McNamee, Paul ^b   Steen, Nick ^c   Bond, John ^c   Griffin, S Michael ^a  

^a Oesophago Gastric Cancer Unit   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ASPIRATION; BLEEDING; CANCER PALLIATIVE THERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVICE FAILURE; DEVICE INFECTION; DEVICE MIGRATION; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS OBSTRUCTION; ESOPHAGUS STRICTURE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS LOOSENING; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF EXPANDING METAL STENT; SENSITIVITY ANALYSIS; STENT; STENT SIZE; TREATMENT FAILURE; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BALLOON DILATATION; CAUSE OF DEATH; CONFIDENCE INTERVALS; CRITICAL ILLNESS; DECISION MAKING; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM INVASIVENESS; PALLIATIVE CARE; PROBABILITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650424006     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.155     Document Type: Article

References (42)

1. Watkinson AF, Ellul J, Entwisle K et al. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology 1995;195:821-7.
2. Knyrim K, Wagner HJ, Bethge N et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329:1302-7.
3. De Palma GD, di Matteo E, Romano G et al. Plastic prosthesis vs. expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 1996;43:478-82.
4. Farndon MA, Wayman J, Clague MB et al. Cost-effectiveness in the management of patients with oesophageal cancer. Br J Surg 1998;85:1394-8.
5. Maydeo AP, Bapaye A, Desai PN et al. Endoscopic placement of indigenous plastic esophageal endoprostheses-does it still have a role in the era of expandable metallic stents? A prospective Indian study in 265 consecutive patients [see comments]. Endoscopy 1998;30:532-7.
6. Roseveare CD, Patel P, Simmonds N et al. Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. Eur J Gastroenterol Hepatol 1998;10:653-7.
7. Dallal HJ, Smith GD, Grieve DC et al. A randomized trial of thermal ablative therapy vs. expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc 2001;54:549-57.
8. Homs MY, Steyerberg EW, Eijkenboom WM et al. Single-dose brachyther-apy vs. metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 2004;364:1497-504.
9. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
10. O'Donnell CA, Fullarton GM, Watt E et al. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer. Br J Surg 2002;89:985-92.
11. Siersema PD, Hop WC, Dees J et al. Coated self-expanding metal stents vs. latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endosc 1998;47:113-20.
12. Shenfine J, McNamee P, Steen N et al. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005;9:iii, 1-121.
13. Siersema PD, Hop WC, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001;54:145-53.
14. Adam A, Ellul J, Watkinson AF et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 1997;202:344-8.
15. Szentpali K, Palotas A, Lazar G et al. Endoscopic intubation with conventional plastic stents: a safe and cost-effective palliation for inoperable esophageal cancer. Dysphagia 2004;19:22-7.
16. Kaplan RM. Behavior as the central outcome in health care. Am Psychol 1990;45:1211-20.
17. Spitzer WO, Dobson AJ, Chesterman E et al. Measuring the quality of life of cancer patients. J Chron Dis 1981;34:585-97.
18. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In Spilker B (ed). Quality of Life Assessments in Clinical Trials. Raven Press: New York, 1990, pp. 11-24.
19. Barr H, Krasner N. Prospective quality-of-life analysis after palliative photo-ablation for the treatment of malignant dysphagia. Cancer 1991;68:1660-4.
20. Brooks R. EuroQol: the current state of play [Review]. Health Policy 1996;37:53-72.
21. Anonymous. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group [see comments]. Health Policy 1990;16:199-208.
22. OΉanlon DM, Callanan K, Karat D et al. Outcome, survival, and costs in patients undergoing intubation for carcinoma of the esophagus. Am J Surg 1997;174:316-9.
23. Blazeby JM, Williams MH, Brookes ST et al. Quality of life measurement in patients with oesophageal cancer. Gut 1995;37:505-8.
24. den Hartog Jager FC, Bartelsman JF, Tytgat GN. Palliative treatment of obstructing esophagogastric malignancy by endoscopic positioning of a plastic prosthesis. Gastroenterology 1979;77:1008-14.
25. Alderson D, Wright PD. Laser recanalization vs. endoscopic intubation in the palliation of malignant dysphagia. Br J Surg 1990;77:1151-3.
26. Ludwig D, Dehne A, Burmester E et al. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy Int J Oncol 1998;13:583-8.
27. Oliver SE, Robertson CS, Logan RF et al. What does radiotherapy add to survival over endoscopic intubation alone in inoperable squamous cell oesophageal cancer? Gut 1990;31:750-2.
28. Raijman I, Siddique I, Lynch P. Does chemoradiation therapy increase the incidence of complications with self-expanding coated stents in the management of malignant esophageal strictures? Am J Gastroenterol 1997;92:2192-6.
29. Schmassmann A, Meyenberger C, Knuchel J et al. Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types. Am J Gastroenterol 1997;92:400-6.
30. Bartelsman JF, Bruno MJ, Jensema AJ et al. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointestinal Endoscopy 2000;51:134-8.
31. Kozarek RA, Raltz S, Marcon N et al. Use of the 25 mm flanged esophageal Z stent for malignant dysphagia: a prospective multicenter trial. Gastrointest Endosc 1997;46:156-60.
32. Verschuur EM, Steyerberg EW, Kuipers EJ et al. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc 2007;65:592-601.
33. Nicholson DA, Haycox A, Kay CL et al. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy. Clin Radiol 1999;54:212-5.
34. Birch JF, White SA, Berry DP et al. A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. Dis Esophagus 1998;11:172-6.
35. Pennathur A, Chang AC, McGrath KM et al. Polyflex expandable stents in the treatment of esophageal disease: initial experience. Ann Thorac Surg 2008;85:1968-72; discussion 1973.
36. Ginsberg GG. Palliation of malignant esophageal Dysphagia: would you like plastic or metal? Am J Gastroenterol 2007;102:2678-9.
37. Conio M, Repici A, Battaglia G et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 2007;102:2667-77.
38. Verschuur EM, Repici A, Kuipers EJ et al. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008;103:304-12.
39. Guo JH, Teng GJ, Zhu GY et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology 2008;247:574-81.
40. Harvey JA, Bessell JR, Beiler E et al. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia. Dis Esophagus 2004;17:260-5.
41. Wong SK, Chiu PW, Leung SF et al. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study. Ann Surg Oncol 2008;15: 576-82.
42. de Raeve L. Ethical issues in palliative care research. Palliat Med 1994;8:298-305.